Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPICY: Adjunctive Divalproex or Risperidone for Aggression in ADHD
NCT00794625Phase 4Unknown
- Start
- Nov 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of divalproex sodium, risperidone in attention deficit hyperactivity disorder (ADHD). Status: unknown.
02
Drugs
divalproex sodiumrisperidone
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00794625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794625.